ES471985A1 - Procedimiento para preparar 6,7-dihidro-5h, 13h-quinazolino -3,2-a(1,4)-benzociazepin-5,13-dionas - Google Patents

Procedimiento para preparar 6,7-dihidro-5h, 13h-quinazolino -3,2-a(1,4)-benzociazepin-5,13-dionas

Info

Publication number
ES471985A1
ES471985A1 ES471985A ES471985A ES471985A1 ES 471985 A1 ES471985 A1 ES 471985A1 ES 471985 A ES471985 A ES 471985A ES 471985 A ES471985 A ES 471985A ES 471985 A1 ES471985 A1 ES 471985A1
Authority
ES
Spain
Prior art keywords
aryl
medicaments
compounds
alkyl
quinazolino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES471985A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19772733681 external-priority patent/DE2733681A1/de
Priority claimed from DE19772758875 external-priority patent/DE2758875A1/de
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES471985A1 publication Critical patent/ES471985A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Procedimiento para preparar 6,7-dihidro-5H,13H-quinazolino[3,2-a][1,4]-benzodiazepin-5,13-dionas de fórmula general (I) **(Fórmula)** en la cual R1 y R5 representan 1,2,3 ó 4 sustituyentes de grupo formado por hidrógeno, alquilo, hidroxi, aciloxi, alcoxi, nitro, amino, alquilamino, dialquilamino, acilamino, acilalquilamino, alcoxicarbonilamino, halógeno, trifluorometilo, ciano, carboxi, alcoxicarbonilo, aminocarbonilo, alquilaminocarbonilo, dialquilaminocarbonilo, aminosulfonilo, alquilaminosulfonilo, dialquilaminosulfonilo, alquilaminocarbonilamino y dialquilaminocarbonilamino; R2 representa hidrógeno, alquilo eventualmente sustituido, aralquilo, arilo o heterocicloalquilo, acilo o alcoxicarbonilo, y R3 y R4 representan sustituyentes iguales o diferentes del grupo formado por hidrógeno, alquilo eventualmente sustituido, aralquilo eventualmente sustituido en la parte arilo, arilo eventualmente sustituido o heteroarilo, y sus sales inobjetables desde el punto de vista de ácidos inorgánicos.
ES471985A 1977-07-26 1978-07-24 Procedimiento para preparar 6,7-dihidro-5h, 13h-quinazolino -3,2-a(1,4)-benzociazepin-5,13-dionas Expired ES471985A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19772733681 DE2733681A1 (de) 1977-07-26 1977-07-26 6,7-dihydro-5h, 13h-chinazolino eckige klammer auf 3,2-a eckige klammer zu eckige klammer auf 1,4 eckige klammer zu benzodiazepin-5,13-dione, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE19772758875 DE2758875A1 (de) 1977-12-30 1977-12-30 6,7-dihydro-5h,13h-chinazolino eckige klammer auf 3,2-a eckige klammer zu eckige klammer auf 1,4 eckige klammer zu benzodiazepin-5,13-dione, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
ES471985A1 true ES471985A1 (es) 1979-10-01

Family

ID=25772398

Family Applications (1)

Application Number Title Priority Date Filing Date
ES471985A Expired ES471985A1 (es) 1977-07-26 1978-07-24 Procedimiento para preparar 6,7-dihidro-5h, 13h-quinazolino -3,2-a(1,4)-benzociazepin-5,13-dionas

Country Status (9)

Country Link
US (1) US4187306A (es)
EP (1) EP0000538A1 (es)
JP (1) JPS5424896A (es)
AU (1) AU3828478A (es)
DK (1) DK330378A (es)
ES (1) ES471985A1 (es)
FI (1) FI782318A7 (es)
IL (1) IL55207A0 (es)
IT (1) IT7826042A0 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4530790A (en) * 1982-12-27 1985-07-23 Merck & Co., Inc. Cholecystokinin antagonists
US4563451A (en) * 1985-01-25 1986-01-07 Merck & Co., Inc. Quinazolino-1,4-benzodiazepin-5,13-diones
US4559338A (en) * 1985-01-25 1985-12-17 Merck & Co., Inc. Soluble quinazolino-1,4-benzodiazepin-5,13-dione derivatives
US4554272A (en) * 1985-01-25 1985-11-19 Merck & Co., Inc. Substituted quinazolino-1,4-benzodiazepin-6,9-diones and their preparation
US4735941A (en) * 1986-12-23 1988-04-05 Merck & Co., Inc. 1,4-benzodiazepines with 5- and 6-membered heterocyclic rings, useful as gastrointestinal and CNS agents
EP0272868A1 (en) * 1986-12-23 1988-06-29 Merck & Co. Inc. 1,4-Benzodiazepines with 6-membered heterocyclic rings
US5670640A (en) * 1996-02-02 1997-09-23 Hoffmann-La Roche Inc. Process for the manufacture of imidazodiazepine derivatives
TWI707859B (zh) * 2017-09-07 2020-10-21 日商衛材R&D企管股份有限公司 五環化合物
MX2021009685A (es) * 2019-03-05 2021-09-10 Eisai R&D Man Co Ltd Compuesto heterociclo pentaciclico.
TWI870286B (zh) * 2019-03-05 2025-01-11 日商衛材R&D企管股份有限公司 五環化合物之鹽及其等之結晶

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3280117A (en) * 1964-04-20 1966-10-18 Sandoz Ag Tricyclic quinazolinones
US3651046A (en) * 1969-01-30 1972-03-21 Hoffmann La Roche Quinazolino-benzodiazepines and methods for the preparation thereof

Also Published As

Publication number Publication date
FI782318A7 (fi) 1979-01-27
JPS5424896A (en) 1979-02-24
US4187306A (en) 1980-02-05
EP0000538A1 (de) 1979-02-07
IT7826042A0 (it) 1978-07-24
AU3828478A (en) 1980-01-31
DK330378A (da) 1979-01-27
IL55207A0 (en) 1978-09-29

Similar Documents

Publication Publication Date Title
NL980043I1 (nl) Chinoline-tussenprodukten voor de synthese van 1H-imidazoc4,5-c!chinolines en 1H-imidazoc4,5-c!chinoline-4-amine.
DK422583A (da) Fremgangsmaade til fremstilling af diazobicyclo-(3,3,1)-nonaner
ES8502669A1 (es) Procedimiento para preparar derivados de 3-bencilidenalcanfor
ES479970A1 (es) Procedimiento para la obtencion de 5,6-dimetilpirrolo-2,3-d-pirimidinas.
ES8103744A1 (es) Un metodo para la preparacion de derivados de ftalimidina
DK164704C (da) 3,6-disubstituerede triazolo-oe3,4-aaa-ftalazinderivater, fremgangsmaade til fremstilling deraf, udgangsforbindelse til anvendelse i fremgangsmaaden samt anvendelse af og farmaceutisk praeparat indeholdende forbindelserne
FR2442845A1 (fr) Derives amines spiranniques, leur preparation et leur utilisation comme medicaments
SE8600913D0 (sv) Kemiska foreningar
ES8407471A1 (es) Procedimiento para preparar derivados de prolina disustituidos
PT97047A (pt) Processo de preparacao de compostos de 1-carboxialquilquinoxalina-2,3(1h,4h)-diona e de composicoes farmaceuticas que os contem
ES468501A1 (es) Un procedimiento para la preparacion de derivados de imida- zodiacepina.
ES479820A1 (es) Procedimiento para la preparacion de isoquinoleinas.
ATE799T1 (de) Verfahren zur herstellung von isatosaeureanhydriden.
IE41509L (en) Process for di- and triamino naphthalene production
ATE11545T1 (de) Gesaettigte aminocyclitderivate, ihre herstellung und sie enthaltende arzneimittel.
GR860090B (en) Methods for the preparation of 1- aryl - 4- nitropyrazole and their use as herbicide
ES458481A1 (es) Un procedimiento de preparacion de nuevos derivados de ben- zodiazepina.
ES464013A1 (es) Procedimiento para preparar derivados sustituidos de orto- fenilendiamina.
ES8501607A1 (es) Procedimiento para la obtencion de heterociclos nitrogenosos de 5 miembros
ES8103081A1 (es) Procedimiento para la obtencion de diazatriciclos
DK256982A (da) Fremgangsmaade til fremstilling af n-phthalidyl-5-flyoruracilderivater
IL116382A0 (en) Trisubstituted t hoxanthines and pharmaceutical compositions containing the same
JPS5418832A (en) Preparation of hetericyclic dyes
AU3022184A (en) Pyridazino (4,3-c) isoquinoline and their use as anti-anxiety agents
ES464480A1 (es) Procedimiento para preparar esteres de acidos bencenosulfonicos sustituidos.